Impact of different physical activities on the health of women in the climacteric

Impact of different types of non-pharmacological interventions on the health of climacteric women: a randomized clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

REBEC

Registry ID

RBR-4djzt48

Enrollment

224

Registered

2026-04-14

Start date

2026-05-04

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

This is a randomized controlled clinical trial with parallel groups lasting 16 weeks to be conducted with climacteric women. The study will evaluate the effect of three systematized nonpharmacological

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Women in the climacteric stage aged between 45 and 70 years; receiving care from primary health care services in Montes Claros, Minas Gerais, Brazil; medically cleared to participate in physical activity through a medical certificate.

Exclusion criteria

Exclusion criteria: Physical or cognitive limitations that prevent participation in the proposed interventions; uncontrolled cardiovascular, respiratory, or musculoskeletal diseases that preclude exercise practice; participation in another structured physical exercise program during the study period; failure to complete baseline assessments.

Design outcomes

Primary

Measure	Time frame
It is expected to observe changes in climacteric symptoms, assessed by the Menopause Rating Scale (MRS), by comparing values obtained at baseline and after 16 weeks of intervention.	—

Secondary

Measure	Time frame
It’s expected to observe change in functional mobility assessed by the Timed Up and Go Test (TUG), measured in seconds to complete a three-meter course, comparing values obtained at baseline and after 16 weeks of intervention.;It’s expected to observe change in lower-limb muscle strength and endurance assessed by the 30-Second Chair Stand Test, considering the number of repetitions performed at baseline and after 16 weeks of intervention.;It’s expected to observe change in abdominal muscle endurance assessed by the Abdominal Curl-Up Test, considering the number of repetitions performed at baseline and after 16 weeks of intervention.;It’s expected to observe change in upper-limb muscular endurance assessed by the Push-Up Test, considering the number of repetitions performed at baseline and after 16 weeks of intervention.;It’s expected to observe change in cardiorespiratory functional capacity assessed by the Six-Minute Walk Test (6MWT), considering the total distance walked in meters, comparing values obtained at baseline and after 16 weeks of intervention.;It’s expected to observe change in anthropometric profile assessed by Body Mass Index (BMI) and waist circumference, comparing values obtained at baseline and after 16 weeks of intervention.;It’s expected to observe change in body composition assessed by bioelectrical impedance analysis (BIA), considering body fat percentage, muscle mass, and total body water.;It’s expected to observe change in the occurrence of sarcopenia, assessed according to diagnostic criteria based on muscle mass, muscle strength, and physical performance.;It’s expected to observe change in the occurrence of dynapenia, assessed by handgrip strength using the Handgrip Strength Test.;It’s expected to observe change in the occurrence of sarcopenic obesity, assessed by the combination of body composition indicators and muscle strength.;It’s expected to observe change in metabolic parameters assessed through laboratory tests, including fasting gl	—

Measure

Time frame

It’s expected to observe change in functional mobility assessed by the Timed Up and Go Test (TUG), measured in seconds to complete a three-meter course, comparing values obtained at baseline and after 16 weeks of intervention.;It’s expected to observe change in lower-limb muscle strength and endurance assessed by the 30-Second Chair Stand Test, considering the number of repetitions performed at baseline and after 16 weeks of intervention.;It’s expected to observe change in abdominal muscle endurance assessed by the Abdominal Curl-Up Test, considering the number of repetitions performed at baseline and after 16 weeks of intervention.;It’s expected to observe change in upper-limb muscular endurance assessed by the Push-Up Test, considering the number of repetitions performed at baseline and after 16 weeks of intervention.;It’s expected to observe change in cardiorespiratory functional capacity assessed by the Six-Minute Walk Test (6MWT), considering the total distance walked in meters, comparing values obtained at baseline and after 16 weeks of intervention.;It’s expected to observe change in anthropometric profile assessed by Body Mass Index (BMI) and waist circumference, comparing values obtained at baseline and after 16 weeks of intervention.;It’s expected to observe change in body composition assessed by bioelectrical impedance analysis (BIA), considering body fat percentage, muscle mass, and total body water.;It’s expected to observe change in the occurrence of sarcopenia, assessed according to diagnostic criteria based on muscle mass, muscle strength, and physical performance.;It’s expected to observe change in the occurrence of dynapenia, assessed by handgrip strength using the Handgrip Strength Test.;It’s expected to observe change in the occurrence of sarcopenic obesity, assessed by the combination of body composition indicators and muscle strength.;It’s expected to observe change in metabolic parameters assessed through laboratory tests, including fasting gl

—

Countries

Contacts

Public ContactJosiane Rocha

Universidade Estadual de Montes Claros

josiane.rocha@unimontes.br+55 (38) 3229-8000

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: May 1, 2026